Follicular fluid microRNAs and ovarian aging linked to IVF outcomes
Official title: Investigating the Role of Follicular Fluid microRNAs in Ovarian Aging and Assisted Reproductive Success
Run by University of Central Florida · NCT07214246 · Data updated 2026-11-12
This project will test whether tiny RNA molecules (exosomal microRNAs) in the fluid around eggs can indicate egg quality and predict IVF success for women under 31 or over 38 undergoing IVF.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | University of Central Florida Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | September 22, 2025 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | October 9, 2025 |
| Trial ID | NCT07214246 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women undergoing IVF for male-factor or other nonovarian reasons who are younger than 31 or older than 38, have regular menstrual cycles, and can provide informed consent are ideal candidates.
✕Probably not a fit
Women aged 32–37 and those with PCOS, endometriosis, ovarian insufficiency, metabolic disorders, prior ovarian surgery or chemotherapy, or other conditions affecting follicular fluid are excluded and unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study that will collect follicular fluid during IVF cycles and isolate exosomal microRNAs for high-throughput sequencing. Researchers will compare miRNA expression profiles between younger (<31) and older (>38) women and correlate identified signatures with oocyte quality and IVF outcomes. Validated exosome isolation and sequencing methods will be used, followed by gene-target and pathway analyses to interpret biological relevance. Findings will be compared with existing preclinical data and may be validated in additional samples.
Why it matters
Potential benefit: If successful, this could enable a noninvasive molecular test using follicular fluid miRNA patterns to better predict which eggs are most likely to lead to a successful IVF pregnancy, especially for older women.
How similar studies have gone: Direct human studies of follicular fluid exosomal miRNAs are limited, though the investigators' rodent studies show clear age-associated miRNA changes that support biological plausibility.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women undergoing IVF treatment due to male factor infertility or nonovarian causes. * Age groups: younger women \<31 years and older women \>38 years. * Regular menstrual cycles. * Willing and able to provide informed consent. Exclusion Criteria: * Minors (under 18 years) and women aged 32-37 years * Diagnosis of polycystic ovarian syndrome (PCOS). * History of recurrent pregnancy loss. * Presence of endometriosis. * Diagnosis of ovarian insufficiency. * Metabolic disorders (e.g., diabetes). * History of ovarian surgery or chemotherapy. * Any condition that might impact follicular fluid quality or IVF outcomes.
Where it's running
-
University of Central Florida
Orlando, Florida, United States Recruiting
Study contacts
- Principal investigator: Michal Masternak, PhD — University of Central Florida
- Study coordinator: Amoy Fraser, PhD, CCRP, PMP
- Email: Amoy.Fraser@ucf.edu
- Phone: 4072668742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reactive Oxygen Species and Reproduction (ROAR)
This study will see if oxidative stress levels in follicular fluid, blood, and sperm are linked to egg quality and IVF success for couples undergoing blastocyst culture with PGS.
-
Using white noise to improve comfort during in vitro fertilization
This study is testing if playing white noise can help women feel more comfortable and less anxious during in vitro fertilization procedures.
-
Day-4 embryo defragmentation to improve blastocyst formation and pregnancy outcomes
This study tests whether removing cytoplasmic fragments from Day-4 morula-stage embryos helps people undergoing ICSI get more blastocysts and better pregnancy chances.
-
How a mother's immune system accepts pregnancy in the first trimester
We will test how the immune system changes in the first trimester in people undergoing IVF to see which immune patterns support implantation and help prevent early miscarriage.
-
Ovarian PRP injections to try to improve embryo quality
This study tries ovarian platelet-rich plasma (PRP) injections to see if they improve embryo development for people doing IVF.
-
Using Super-GDF9 to Improve Oocyte Quality in In Vitro Fertilization
This study is testing if adding Super-GDF9 can help improve egg quality during a specific fertility treatment for women with PCOS who are looking for a safer and more affordable alternative to traditional IVF.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.